PUBLISHER: The Business Research Company | PRODUCT CODE: 1951594
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951594
Cell therapy raw materials are the essential substances and components used in the development, manufacturing, and processing of cell-based therapies. These materials play a critical role in preserving the quality, uniformity, and safety of cell cultures across different stages of therapy production.
The main types of cell therapy raw materials include stem cell-based raw materials, gene therapy raw materials, and CAR-T cell therapy raw materials. Stem cell-based raw materials are specialized inputs designed to support the growth, maintenance, and differentiation of stem cells used in cell therapy research and manufacturing. The product portfolio includes media, sera, cell culture supplements, antibodies, reagents and buffers, and others, and these materials are extensively utilized by end users such as biopharmaceutical and pharmaceutical companies, contract research and manufacturing organizations, and others.
Tariffs have impacted the cell therapy raw materials market by increasing costs for imported reagents, antibodies, and specialized cell culture components, affecting overall manufacturing expenses. Segments such as gene therapy and CAR-T cell therapy raw materials are most affected, particularly in regions like North America and Asia-Pacific that rely on global supply chains. These tariffs have led to pricing pressures and procurement challenges. However, they have also encouraged local production, supplier diversification, and investment in domestic raw material manufacturing capabilities.
The cell therapy raw materials market research report is one of a series of new reports from The Business Research Company that provides cell therapy raw materials market statistics, including cell therapy raw materials industry global market size, regional shares, competitors with a cell therapy raw materials market share, detailed cell therapy raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy raw materials industry. This cell therapy raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell therapy raw materials market size has grown exponentially in recent years. It will grow from $5.07 billion in 2025 to $6.1 billion in 2026 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to early-stage development of cell therapies, reliance on animal-derived sera, limited scalability of cell culture processes, growing academic and clinical research in cell therapy, increasing investment in regenerative medicine.
The cell therapy raw materials market size is expected to see exponential growth in the next few years. It will grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to commercialization of cell and gene therapies, rising demand for car-t treatments, advancements in cell expansion and cryopreservation materials, increasing regulatory scrutiny on raw material quality, expansion of biopharmaceutical manufacturing capacity. Major trends in the forecast period include rising demand for high-quality and consistent cell culture media, increasing adoption of serum-free and chemically defined raw materials, growth in car-t and gene therapy manufacturing pipelines, expansion of outsourcing to specialized raw material suppliers, enhanced focus on regulatory compliance and traceability.
The growing adoption of regenerative medicine is expected to drive the growth of the cell therapy raw materials market in the coming years. Regenerative medicine is a medical field focused on restoring normal function by replacing, engineering, or regenerating human cells, tissues, or organs. The expansion of regenerative medicine is driven by the increasing burden of chronic and degenerative diseases, which is fueling demand for therapies that repair or replace damaged tissues rather than merely managing symptoms. Cell therapy raw materials support regenerative medicine by supplying essential components such as growth factors, cell culture media, enzymes, and scaffolds required to cultivate, expand, and maintain therapeutic cells used in tissue and organ repair or regeneration. For instance, in January 2025, according to the National Library of Medicine, a US-based biomedical library, 32 new gene therapies, including genetically modified cell therapies, were approved in 2024. Therefore, the growing use of regenerative medicine is driving the growth of the cell therapy raw materials market.
Major companies operating in the cell therapy raw materials market are focusing on developing innovative solutions, such as good manufacturing practice (GMP)-compliant manufacturing, to ensure product safety, consistency, and regulatory compliance throughout the cell therapy production process. GMP-compliant manufacturing refers to systems and processes that ensure products are consistently produced and controlled according to quality standards established by regulatory authorities, minimizing risks associated with pharmaceutical and biotechnological manufacturing. For example, in April 2025, Thermo Fisher Scientific Inc., a US-based life science and clinical research company, launched an advanced therapies collaboration center (ATxCC) in the United States to support the development and commercialization of cell and gene therapies. This center accelerates cell therapy development by offering end-to-end cGMP manufacturing support, advanced technologies, and expert process optimization, while fostering collaboration to address manufacturing challenges and accelerate commercialization.
In January 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Akron Biotechnology to strengthen cell therapy manufacturing by integrating cGMP-compliant cytokines into Charles River's Flex Platform. This partnership aims to streamline processing, improve scalability, and ensure regulatory compliance for advanced therapies. Akron Biotechnology is a US-based manufacturing company specializing in raw materials for cell and gene therapy development.
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell therapy raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell therapy raw materials market consists of sales of serum and serum-free supplements, cryopreservation systems, and buffer systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Therapy Raw Materials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cell therapy raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cell therapy raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy raw materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.